As­traZeneca hands over opi­oid ad­dic­tion pill to Eo­las; Tande­mAI, Per­pet­u­al Med­i­cines merge

Plus, news about Pfiz­er and Astel­las’ Xtan­di, BeOne Med­i­cines, Bio­cy­to­gen and Rhythm:

Eo­las Ther­a­peu­tics takes opi­oid ad­dic­tion pill from As­traZeneca: The biotech

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER